Prnewswire Alebund Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire alebund pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Alebund Pharmaceuticals Today - Breaking & Trending Today

Alebund Pharmaceuticals Raises $54.5 Million in Series B+ Financing Round to Fuel Development of Renal Disease Treatment

Alebund Pharmaceuticals Raises $54.5 Million in Series B+ Financing Round to Fuel Development of Renal Disease Treatment
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Jacky Chen , Gavin Xia , Roy Xie , Minchuan Wang , Nick Maounis , Randy Lin , Marietta Wu , H Health Investment , Verition Fund Management , Alebund Pharmaceuticals , Prnewswire Alebund Pharmaceuticals , Fund Of Funds , Health Investment , Loyal Valley Capital , Morningside Ventures , Yuanbio Venture Capital , Octagon Capital , Existing Shareholders , Lilly Asia Ventures , Quan Capital , Bioventures Capital , Sherpa Healthcare Partners , Chief Executive Officer , Loyal Valley ,

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
News provided by
Share this article
Share this article
SHANGHAI, May 9, 2021 /PRNewswire/ Alebund Pharmaceuticals ( Alebund or the Company ), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised $60 million in its Series B financing round which was led by Quan Capital, and followed by a prominent sovereign wealth fund, 3E Bioventures Capital, and Sherpa Healthcare Partners. Existing Shareholders, Lilly Asia Ventures and Med-Fine Capital, also took part in this financing round. Proceeds raised from this round will be invested in the research and development of pre-clinical assets, clinical programs, the construction of the manufacturing site, and the expansion of Comp ....

United States , Gavin Xia , Yi Shi , Marietta Wu , Alebund Pharmaceuticals , Prnewswire Alebund Pharmaceuticals , Quan Capital , Bioventures Capital , Sherpa Healthcare , Existing Shareholders , Lilly Asia Ventures , Med Fine Capital , Chief Executive Officer , Chief Medical Officer , Managing Director , Lilly Asia , Aisa Ventures , Huagai Capital , Asia Ventures , Menlo Park , Gai Capital , San Francisco Bay Area , Healthcare Partners , ஒன்றுபட்டது மாநிலங்களில் , இ ஷி , மரியெட்டா வு ,